Goodmorning Bulldog2, the thing that needs to be looked at is these Series B preferred shares they awarded themselves to always have majority voting power. They received these shares from the blank preferred checkbook which was supposedly included and voted upon when they raised the A/S to 500M. Due to these Series B preferred shares they continue to raise the A/S & award themselves these lucrative bonuses without a fight from any of the Common Shareholders who own 95.5% of the Company (All executive officers & directers as a group own 4.75% per Proxy Statement). The Common Shareholders who have funded Muscle Pharm to were it is today have no say whatsoever on the decisions of this Company. Seems criminal to me. The very least they owe us a Shareholders Conference Call to answer Shareholder questions & concerns.
Market Data 
Markets 
AI
